MultiCell Technologies Listing on Berlin-Bremen Stock Exchange Is Unauthorized
WARWICK, R.I.
MultiCell Technologies, Inc.
Jerry Newmin, 401-738-7560
MultiCell Technologies, Inc. (the Company)(OTCBB:EXTI) learned yesterday that it is one of over 200 publicly traded U.S. companies whose stock has been listed on the Berlin-Bremen Stock Exchange without the Company's prior knowledge, consent or authorization. The Company has requested immediate removal of the Company from the exchange.
Investors interested in the purchase of shares of MultiCell should purchase their shares from authorized broker-dealers and shares listed on the NASDAQ Over The Counter Bulletin Board (OTCBB) under the symbol, EXTI, as shares traded on the Berlin-Bremen Stock Exchange or any other foreign exchange are not currently recognized by MultiCell Technologies, Inc.
About MultiCell
MultiCell Technologies, Inc., provides hepatic (liver) cells and cell lines to pharmaceutical companies for drug discovery, and is developing cell-based toxicological and drug screening tests and biologics for use in diagnostic and therapeutic applications. MultiCell's cellular product expertise also enables production of liver-derived therapeutic proteins. The Company's majority-owned Xenogenics subsidiary is developing the Sybiol(R) synthetic bio-liver device. MultiCell's corporate and research headquarters are at 55 Access Road, Suite 700, Warwick RI, 02886. (401) 738-7560. For more information visit www.exten.com and www.multicelltechnologies.com.
Additional Information: The EXTI.OB stock ticker symbol remains the same until further notice. Assignment of a new symbol is expected as a result of the recent corporate consolidation and name change.
The matters set forth in this press release are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks are detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission including the company's Annual Report, Quarterly Reports and other periodic filings. These forward-looking statements speak only as of the date hereof. The company disclaims any intent or obligation to update these forward-looking statements.
app.quotemedia.com |
